Rule changes at the Patent Trial and Appeal Board became effective in May. But practitioners tell Michael Loney they are struggling to see their impact. Some also call for the Board to go over its 12-month deadline for final written decisions in extraordinary circumstances
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Abbott winning another round against Sinocare and Menarini, and 'long arm' clarification on the UK's position within the UPC, were also among major developments
Executive chair Matt Dixon, who reveals a new associate hire, says the firm wants to offer a realistic pathway to partnership while avoiding the ‘corporate machine’ route